title: Ibrutinib in CLL: 2 sides of the same coin.
authors.affiliation: UNIVERSITY HOSPITAL VALL D'HEBRON.
authors.forename: Francesc
authors.identifier: http://orcid.org/0000-0001-9241-2886
authors.initials: F
authors.lastname: Bosch
authors.affiliation: UNIVERSITY HOSPITAL VALL D'HEBRON.
authors.forename: Pau
authors.initials: P
authors.lastname: Abrisqueta
mesh_terms: D001402:B-Lymphocytes; D005260:Female; D006801:Humans; D056724:Immunity, Humoral / Q000187:drug effects*; D007136:Immunoglobulins; D007239:Infections; D015451:Leukemia, Lymphocytic, Chronic, B-Cell; D008297:Male; D011720:Pyrazoles / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D020127:Recovery of Function
chemical_list: D007136:Immunoglobulins; D011720:Pyrazoles; D011743:Pyrimidines